The UK Health Security Agency (UKHSA), in partnership with devolved administrations, has developed a dynamic risk assessment methodology to inform ministerial decisions on red and green list countries and the associated border measures against the risks of importing cases of SARS-CoV-2 and its variants.
Available and relevant sources of information for each country or territory are used to provide an overall assessment on:
genomic surveillance capability
SARS-CoV-2 transmission risk
variant of concern (VOC) transmission risk
Decisions are taken by ministers informed by evidence, including analysis by UKHSA as well as other relevant public health factors.
A summary of key data used by UKHSA to inform the latest round of assessments is shown in the tables.
The Joint Biosecurity Centre (JBC), part of the UK Health Security Agency, in partnership with devolved administrations, has developed a dynamic risk assessment methodology to inform ministerial decisions on red and green list countries and the associated border measures against the risks of importing cases of SARS-CoV-2 and its variants.
Available and relevant sources of information for each country or territory are used to provide an overall assessment on:
Decisions are taken by ministers informed by evidence including JBC’s analysis as well as other relevant public health factors.
A summary of key data used by JBC to inform the latest round of assessments is shown in the tables.
The Joint Biosecurity Centre (JBC), part of the UK Health Security Agency, in partnership with devolved administrations, has developed a dynamic risk assessment methodology to inform ministerial decisions on red, amber and green list countries and the associated border measures against the risks of importing cases of SARS-CoV-2 and its variants.
Available and relevant sources of information for each country or territory are used to provide an overall assessment on:
Decisions are taken by ministers informed by evidence including JBC’s analysis as well as other relevant public health factors.
A summary of key data used by JBC to inform the latest round of assessments is shown in the tables.
The Joint Biosecurity Centre (JBC), part of the UK Health Security Agency, in partnership with devolved administrations, has developed a dynamic risk assessment methodology to inform ministerial decisions on red and green list countries and the associated border measures against the risks of importing cases of SARS-CoV-2 and its variants.
Available and relevant sources of information for each country or territory are used to provide an overall assessment on:
Decisions are taken by ministers informed by evidence including JBC’s analysis as well as other relevant public health factors.
A summary of key data used by JBC to inform the latest round of assessments is shown in the tables.
The Joint Biosecurity Centre (JBC), part of the UK Health Security Agency, in partnership with devolved administrations, has developed a dynamic risk assessment methodology to inform ministerial decisions on red, amber and green list countries and the associated border measures against the risks of importing cases of SARS-CoV-2 and its variants.
Available and relevant sources of information for each country or territory are used to provide an overall assessment on:
Decisions are taken by ministers informed by evidence including JBC’s analysis as well as other relevant public health factors.
A summary of key data used by JBC to inform the latest round of assessments is shown in the tables.
The UK Health Security Agency (UKHSA), in partnership with devolved administrations, has developed a dynamic risk assessment methodology to inform ministerial decisions on red and green list countries and the associated border measures against the risks of importing cases of SARS-CoV-2 and its variants.
Available and relevant sources of information for each country or territory are used to provide an overall assessment on:
Decisions are taken by ministers informed by evidence, including analysis by UKHSA as well as other relevant public health factors.
A summary of key data used by UKHSA to inform the latest round of assessments is shown in the tables.
The Joint Biosecurity Centre (JBC), part of the UK Health Security Agency, in partnership with devolved administrations, has developed a dynamic risk assessment methodology to inform ministerial decisions on red, amber and green list countries and the associated border measures against the risks of importing cases of SARS-CoV-2 and its variants.
Available and relevant sources of information for each country or territory are used to provide an overall assessment on:
Decisions are taken by ministers informed by evidence including JBC’s analysis as well as other relevant public health factors.
A summary of key data used by JBC to inform the latest round of assessments is shown in the tables.
The Joint Biosecurity Centre (JBC), part of UKHSA, in partnership with devolved administrations, has developed a dynamic risk assessment methodology to inform ministerial decisions on red and green list countries and the associated border measures against the risks of importing cases of SARS-CoV-2 and its variants.
Available and relevant sources of information for each country or territory are used to provide an overall assessment on:
Decisions are taken by ministers informed by evidence including JBC’s analysis as well as other relevant public health factors.
A summary of key data used by JBC to inform the latest round of assessments is shown in the tables.
The Joint Biosecurity Centre (JBC), part of the UK Health Security Agency, in partnership with devolved administrations, has developed a dynamic risk assessment methodology to inform ministerial decisions on red and green list countries and the associated border measures against the risks of importing cases of SARS-CoV-2 and its variants.
Available and relevant sources of information for each country or territory are used to provide an overall assessment on:
Decisions are taken by ministers informed by evidence including JBC’s analysis as well as other relevant public health factors.
A summary of key data used by JBC to inform the latest round of assessments is shown in the tables.
The UK Health Security Agency (UKHSA), in partnership with devolved administrations, has developed a dynamic risk assessment methodology to inform ministerial decisions on red and green list countries and the associated border measures against the risks of importing cases of SARS-CoV-2 and its variants.
Available and relevant sources of information for each country or territory are used to provide an overall assessment on:
genomic surveillance capability
SARS-CoV-2 transmission risk
variant of concern (VOC) transmission risk
Decisions are taken by ministers informed by evidence, including analysis by UKHSA as well as other relevant public health factors.
A summary of key data used by UKHSA to inform the latest round of assessments is shown in the tables.
The Joint Biosecurity Centre (JBC), part of the UK Health Security Agency, in partnership with devolved administrations, has developed a dynamic risk assessment methodology to inform ministerial decisions on red, amber and green list countries and the associated border measures against the risks of importing cases of SARS-CoV-2 and its variants.
Available and relevant sources of information for each country or territory are used to provide an overall assessment on:
Decisions are taken by ministers informed by evidence including JBC’s analysis as well as other relevant public health factors.
A summary of key data used by JBC to inform the latest round of assessments is shown in the tables.
The Joint Biosecurity Centre (JBC), part of the UK Health Security Agency, in partnership with devolved administrations, has developed a dynamic risk assessment methodology to inform ministerial decisions on red, amber and green list countries and the associated border measures against the risks of importing cases of SARS-CoV-2 and its variants.
Available and relevant sources of information for each country or territory are used to provide an overall assessment on:
Decisions are taken by ministers informed by evidence including JBC’s analysis as well as other relevant public health factors.
A summary of key data used by JBC to inform the latest round of assessments is shown in the tables.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
The UK Health Security Agency (UKHSA), in partnership with devolved administrations, has developed a dynamic risk assessment methodology to inform ministerial decisions on red and green list countries and the associated border measures against the risks of importing cases of SARS-CoV-2 and its variants.
Available and relevant sources of information for each country or territory are used to provide an overall assessment on:
genomic surveillance capability
SARS-CoV-2 transmission risk
variant of concern (VOC) transmission risk
Decisions are taken by ministers informed by evidence, including analysis by UKHSA as well as other relevant public health factors.
A summary of key data used by UKHSA to inform the latest round of assessments is shown in the tables.